Shanghai Pharma and Astellas Forge Strategic Collaboration for Commercialization of Zolbetuximab in China

Apr 11, 2025 09:34 CST Updated 09:34

Shanghai Pharma

Modern Pharmaceutical Supply Chain Service Provider

Astellas

Pharmaceutical R&D Manufacturer

On April 10, Shanghai Pharmaceutical Co., Ltd. and Astellas held a strategic cooperation signing ceremony. Zhao Ping, Chairman and President of Astellas China, Chen Zhiyi, Head of Multi-Channel and Key Account Management Division of Astellas China, Li Yongzhong, Executive Director and Executive President of Shanghai Pharmaceuticals, Song Lulu, Vice General Manager of Shanghai Pharmaceutical Co., Ltd., and other leaders from both parties attended the event.。

This signing opens a new chapter in the cooperation between the two parties. Based on Astellas' expertise in research and development and provisionThe leading advantage in innovative drugs, combined with the rich management experience of Shanghai Pharmaceutical Co., Ltd.'s full life cycle service platform for innovative drugs, both parties will carry out comprehensive and in-depth cooperation around the commercial launch of Astellas' new product "Zolbetuximab for Injection" in mainland China.。

Peng Zhao stated: "Astellas has achieved remarkable results in the global and Chinese markets over the past year, and is currently in a stage of vigorous development. In response to the limited treatment options for patients with advanced gastric cancer in China, the launch of Zolbetuximab Injection provides a breakthrough treatment option. We look forward to achieving a win-win cooperation with Shanghai Pharmaceutical Co., Ltd. through this collaboration, further enhancing the drug accessibility for Chinese patients."

Li Yongzhong stated: "As a global leader in the pharmaceutical industry, Astellas has maintained a close partnership with Shanghai Pharmaceutical Co., Ltd. over the long term. Both parties are partners with deep ties. As one of the largest drug import platform enterprises in China, Shanghai Pharmaceutical Co., Ltd. is honored to support the commercial launch of this major new product from Astellas. Adhering to the concept of 'Service as Honor,' Shanghai Pharmaceutical Co., Ltd. will fully leverage its advantages as an innovative drug lifecycle platform to accelerate market access for Astellas' products, ensuring that high-quality medicines reach patients more quickly."

This strategic cooperation marks a new era of collaboration between the two parties. Shanghai Pharmaceutical Co., Ltd. will help Astellas accelerate the commercialization of its new products in China, while relying on...Leveraging their own strengths and innovation-driven capabilities to provide patients with more efficient and high-quality services. Both parties will also join hands to promote the high-quality development of the pharmaceuticals industry, contributing together to the achievement of the "Healthy China 2030" goals.

Company Profile

AstellasAstellas is a global life sciences company driven by innovation and focused on cutting-edge fields. It concentrates on disease areas such as oncology, ophthalmology, urology, transplant immunology, and women's health, providing groundbreaking medical solutions. Its products are accessible in 103 markets worldwide. Astellas' R&D focuses on oncology, gene regulation, blindness, and regeneration, adopting a research strategy targeting unmet medical needs, diseases with high biological relevance, and therapeutic technologies. Astellas is committed to becoming a leader in China’s oncology treatment and specialized fields.

Shanghai Pharmaceutical Co.,Ltd.Shanghai Pharmaceutical Co., Ltd. is a national modern pharmaceutical supply chain service enterprise centered on medical and health services. The company has developed into one of the largest, most extensive, and strongest pharmaceutical trading enterprises in China. Shanghai Pharmaceutical focuses on establishing a nationwide terminal network, actively promoting hospital supply chain services, and building new industrial advantages. The company deepens service innovation, accelerates industrial breakthroughs, and is committed to constructing a national-level pharmaceutical supply chain service platform.

Source: [Shanghai Pharmaceutical Co.,Ltd.] WeChat Official Account